Yoon Seong Choi

Yoon Seong Choi

Auto-generated profile, based on publicly available information

Yoon Seong Choi

Department of Carbon Hybrid Fiber Science, Kyungpook National University, Daegu, Republic of Korea

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
JYJong-pil Yoon
Jong-pil Yoon
HKHyunjin Kim
Hyunjin Kim
DKDong Hyun Kim
Dong Hyun Kim
YCYoon Seong Choi
Yoon Seong Choi
HLHyun Joo Lee
Hyun Joo Lee
Seok Won ChungSeok Won Chung
Seok Won Chung
Background: Multiple factors, such as muscle fatty infiltration (FI), tendon collagen content, and collagen arrangement, determine bone-tendon interface (BTI) healing after rotator cuff (RC) repair. Purpose: To evaluate the effects of systemic administration of ezetimibe-atorvastatin (EZE/ATZ) combination on muscle FI and tendon collagen density and arrangement in an RC repair rat model. Study design: Controlled laboratory study. Methods: A total of 26 male Sprague-Dawley rats were randomly divided equally into control and EZE/ATZ groups and subjected to RC tendon repair surgery. Postoperatively, the EZE/ATZ group rats received a combination of EZE (10 mg/kg/d) and ATZ (20 mg/kg/d) for 4 weeks, after which they were sacrificed. Oil Red O staining was used to assess FI in the supraspinatus muscle. The expression of biomarkers related to muscle atrophy and FI was measured using quantitative real-time polymerase chain reaction. For the qualitative and quantitative analysis of FI-related biomarkers, immunohistochemical staining was performed. Biomechanical and histological analyses were performed to evaluate the quality of BTI healing after RC repair. Results: The EZE/ATZ group showed significantly lower FI compared with the control group ( P < .001) and significantly downregulated expression of gene markers related to muscle atrophy and FI. On histological analysis, the EZE/ATZ group exhibited increased collagen type I contents, consistent collagen arrangement ( P = .005), and significantly higher collagen density ( P = .003) compared with the control group. Biomechanical analysis of the BTI healing revealed that the EZE/ATZ group had significantly increased ultimate strength ( P = .006) compared with the control group. Conclusion: Systemic EZE/ATZ administration suppressed supraspinatus FI by downregulating muscle atrophy–related and FI-related genes after RC repair. Additionally, EZE/ATZ use improved collagen biosynthesis, density, and arrangement at the BTI and significantly increased tensile strength. Clinical Relevance: The results of the current study strongly advocate the use of EZE/ATZ to improve shoulder function and tendon healing after RC repair.

26 December 2024 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
JYJong-pil Yoon
Jong-pil Yoon
HKHyunjin Kim
Hyunjin Kim
DKDong-Hyun Kim
Dong-Hyun Kim
YCYoon Seong Choi
Yoon Seong Choi
HLHyun Joo Lee
Hyun Joo Lee
SCSeok Won Chung
Seok Won Chung

12 September 2025 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
JYJong-pil Yoon
Jong-pil Yoon
HKHyunjin Kim
Hyunjin Kim
DKDong Hyun Kim
Dong Hyun Kim
YCYoon Seong Choi
Yoon Seong Choi
HLHyun Joo Lee
Hyun Joo Lee
Seok Won ChungSeok Won Chung
Seok Won Chung
Background: Despite rotator cuff (RC) tendon repair surgery, fatty infiltration (FI) often progresses due to muscle unloading. Purpose: To evaluate the effects of liraglutide on enhancing muscle quality and function in a rat model of RC tendon repair. Study Design: Controlled laboratory study. Methods: A total of 40 male Sprague-Dawley rats were randomly divided into the control and liraglutide groups and subjected to RC tendon repair surgery. After surgery, rats in the liraglutide group were administered liraglutide (250 µg/kg) for 12 weeks and then sacrificed. Oil Red O staining was used to evaluate the FI of the supraspinatus muscle. The expression of biomarkers related to muscle atrophy, FI, and fat browning was measured by quantitative real-time polymerase chain reaction. Range of motion tests, a wire hanging test, and electromyography were performed to evaluate shoulder function. Results: The liraglutide treatment group demonstrated a significantly lower body mass index and reduced FI compared with the control group. However, no significant differences were observed in the expression levels of genes related to muscle atrophy and FI. Similarly, there was no significant difference in the expression of uncoupling protein 1 (UCP1), a gene associated with fat browning. In the evaluation of shoulder motor function, internal rotation improved early after RC surgery, while external rotation showed improvement at a later stage. In the assessment of muscle strength, the liraglutide group exhibited significant improvement. Furthermore, in the evaluation of compound muscle action potential (CMAP), the liraglutide treatment group showed significant improvement in CMAP both early and late after surgery. Conclusion: The systemic administration of liraglutide suppresses FI without causing muscle loss after RC tendon repair. Furthermore, liraglutide has significant potential to improve shoulder function and quality. Clinical Relevance: This multifaceted mechanism of liraglutide in RC tear treatment may be a powerful clinical strategy for postoperative prognosis management in obese patients with RC tear.

20 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
YCYoon Seong Choi
Yoon Seong Choi
JPJang Ho Park
Jang Ho Park
TLTaewoo Lee
Taewoo Lee
JKJae Hun Kim
Jae Hun Kim
KCKyeongwoon Chung
Kyeongwoon Chung
SHSula Han
Sula Han
The valorization of Sargassum horneri, an abundant brown macroalga in East Asia, offers an opportunity to develop bioactive materials while addressing biomass-management challenges. In this study, S. horneri extract (SHE) was incorporated into electrospun polylactic acid (PLA) nanofiber sheets at 0, 0.2, 0.6, and 1.0%, denoted SHE0/PLA, SHE2/PLA, SHE6/PLA, and SHE10/PLA, respectively. SHE incorporation reduced the mean fiber diameter from 502.28 nm for SHE0/PLA to 355.64, 363.06, and 308.96 nm for SHE2/PLA, SHE6/PLA, and SHE10/PLA, respectively, while the tensile strength remained within a narrow range. SHE10/PLA exhibited 99.9% antibacterial activity against both Staphylococcus aureus and Klebsiella pneumoniae, and DPPH radical-scavenging activity increased with SHE content. The nanofiber-sheet extracts did not markedly reduce human fibroblast viability, and SHE6/PLA and SHE10/PLA promoted scratch closure to approximately 97.5% after 24 h. In a full-thickness wound model in Sprague-Dawley rats, SHE10/PLA showed the smallest residual wound area on day 14 and qualitatively enhanced re-epithelialization and collagen-rich tissue formation. These results indicate that SHE-loaded PLA nanofiber sheets combine antibacterial, antioxidant, and wound-healing-related functions and provide a potential route for the value-added utilization of S. horneri biomass.